Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy-Reference-Cited by-同舟云学术

Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy

Published:2004-06-14 Issue:2 Volume:101 Page:317-324
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bonnet Fabrice,Lewden Charlotte,May Thierry,Heripret Laurence,Jougla Eric,Bevilacqua Sibylle,Costagliola Dominique,Salmon Dominique,Chêne Geneviève,Morlat Philippe

Funder

Agence Nationale de Recherche sur le Sida Coordinated Action No. 5 (AC5)

Sidaction-Ensemble Contre le Sida 12th Call for Tender

Association des Professeurs de Pathologie Infectieuse et Tropicale

the Fédération Nationale des Centres de Lutte Contre le Sida

the Société Nationale Française de Médecine Interne

the Société de Pathologie Infectieuse de Langue Française

the Centre d'Information et de Soins de l'Immunodéficience Humaine

the Réseau Ville-Hôpital

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Survival after introduction of HAART in people with known duration of HIV-1 infection;CASCADE Collaboration;Lancet,2000

2. AIDS across Europe, 1994-98: the EuroSIDA study;Mocroft;Lancet,2000

3. Causes of death in HIV-infected adults in the era of highly active antiretroviral therapy (HAART): the French survey Mortalité 2000;Lewden;Antivir Ther,2003

4. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999;Bonnet;HIV Med,2002

5. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study;Mocroft;AIDS,2002

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up;Journal of Cancer Research and Clinical Oncology;2023-11-26

2. Hematological damage and risk factors prediction in HIV-infected patients with secondary malignancies：A single-center study from China;2023-04-17

3. HIV and neoplasms: What do we know so far?;einstein (São Paulo);2023

4. Activation of IL1 signaling molecules by Kaposi’s sarcoma-associated herpesvirus;Frontiers in Cellular and Infection Microbiology;2022-11-15

5. Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer;Cancer Medicine;2022-10